Cost-Effectiveness Analyses of Hepatitis A Vaccine

@article{Anonychuk2012CostEffectivenessAO,
  title={Cost-Effectiveness Analyses of Hepatitis A Vaccine},
  author={A. Anonychuk and A. Tricco and C. Bauch and B. Pham and V. Gilca and B. Duval and A. John-Baptiste and G. Woo and M. Krahn},
  journal={PharmacoEconomics},
  year={2012},
  volume={26},
  pages={17-32}
}
  • A. Anonychuk, A. Tricco, +6 authors M. Krahn
  • Published 2012
  • Medicine
  • PharmacoEconomics
  • Cost-effectiveness/cost-utility studies of hepatitis A vaccine were identified via a series of literature searches (MEDLINE, EMBASE, HSTAR and SSCI). Citations and full-text articles were reviewed independently by two reviewers. Reference searching, author searches and expert consultation ensured literature saturation. Incremental cost-effectiveness ratios (ICERs) were abstracted for base-case analyses, converted to $US, year 2005 values, and categorised to reflect various levels of cost… CONTINUE READING
    22 Citations
    Hepatitis A immunisation in persons not previously exposed to hepatitis A.
    • 27

    References

    SHOWING 1-10 OF 100 REFERENCES
    Bias in published cost effectiveness studies: systematic review
    • 329
    • PDF
    Cost Effectiveness of Hepatitis A Prevention in France
    • 10